Different low doses of broad‐band UVA in the treatment of morphea and systemic sclerosis: a clinico‐pathologic study

M El‐Mofty, W Mostafa, M El‐Darouty… - Photodermatology …, 2004 - Wiley Online Library
Background: Numerous treatment modalities, some with potentially hazardous side effects,
are currently used for morphea (M) and systemic sclerosis (SS) with limited success. Low …
被引用次数：99 相关文章

Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis

M El-Mofty, W Mostafa, M El-Darouty… - Photodermatology …, 2004 - elibrary.ru
Background Numerous treatment modalities, some with potentially hazardous side effects,
are currently used for morphea (M) and systemic sclerosis (SS) with limited success. Low …

Different low doses of broad‐band UVA in the treatment of morphea and systemic sclerosis

M El‐Mofty, W Mostafa, M El‐Darouty… - Photodermatology …, 2004 - cir.nii.ac.jp
抄録< jats: p>< jats: bold> Background:</jats: bold> Numerous treatment modalities, some
with potentially hazardous side effects, are currently used for morphea (M) and systemic …

Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis.

M El-Mofty, W Mostafa, M El-Darouty… - Photodermatology …, 2004 - search.ebscohost.com
Background: Numerous treatment modalities, some with potentially hazardous side effects,
are currently used for morphea (M) and systemic sclerosis (SS) with limited success. Low …

[引用][C] Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis: A clinico-pathologic study

M EL-MOFTY, W MOSTAFA… - Photodermatology …, 2004 - pascal-francis.inist.fr
Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis:
A clinico-pathologic study CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis.

M El-Mofty, W Mostafa, M El-Darouty… - Photodermatology …, 2004 - europepmc.org
Background Numerous treatment modalities, some with potentially hazardous side effects,
are currently used for morphea (M) and systemic sclerosis (SS) with limited success. Low …
[PDF] bosseila-skintopia.com

[PDF][PDF] Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis A clinico-pathologic study

M El-Mofty, W Mostafa, M El-Darouty… - Photodermatol …, 2004 - bosseila-skintopia.com
Background: Numerous treatment modalities, some with potentially hazardous side effects,
are currently used for morphea (M) and systemic sclerosis (SS) with limited success. Low …

Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis

M El-Mofty, W Mostafa, M El-Darouty… - Photodermatology …, 2004 - pubmed.ncbi.nlm.nih.gov
Background Numerous treatment modalities, some with potentially hazardous side effects,
are currently used for morphea (M) and systemic sclerosis (SS) with limited success. Low …